Literature DB >> 22510179

Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck.

Bruce Peat1, Phillip Insull, Rebecca Ayers.   

Abstract

BACKGROUND: The purpose of the study was to develop a system of risk stratification, based on clinical and histological factors that would aid prediction of metastasis from cutaneous squamous cell carcinoma (SCC) of the head and neck.
METHOD: The method used was a retrospective case control study comparing clinical and histological parameters of 78 patients who developed metastasis with 92 patients who did not develop metastasis over a 5-year period.
RESULTS: The two 'absolute' (highest) risk factors for development of metastatic disease are poor histological differentiation and perineural/lymphovascular infiltration. The three 'relative' risk factors are moderate histological differentiation, diameter ≥20 mm and Clark level 5. RISK STRATIFICATION: High-risk lesions have either one of the absolute risk factors or all three of the relative risk factors with a predicted incidence of metastasis of 37%. Intermediate risk lesions have two of three relative risk factors and a predicted incidence of metastasis of 5%. Low-risk lesions have one or none of the relative risk factors and a predicted incidence of metastasis of 0.3%.
CONCLUSION: Ongoing management of patients with histo-pathologically proven invasive SCC of the head and neck should be based upon risk stratification for metastasis.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22510179     DOI: 10.1111/j.1445-2197.2011.05994.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  8 in total

Review 1.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

2.  Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.

Authors:  Wai Keat Wong; Randall P Morton
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-14       Impact factor: 2.503

Review 3.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.

Authors:  Agnieszka K Thompson; Benjamin F Kelley; Larry J Prokop; M Hassan Murad; Christian L Baum
Journal:  JAMA Dermatol       Date:  2016-04       Impact factor: 10.282

4.  Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines.

Authors:  Melinda B Chu; Jordan B Slutsky; Maulik M Dhandha; Brandon T Beal; Eric S Armbrecht; Ronald J Walker; Mark A Varvares; Scott W Fosko
Journal:  J Skin Cancer       Date:  2014-09-17

Review 5.  Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review.

Authors:  Joshua Lubov; Mathilde Labbé; Krystelle Sioufi; Grégoire B Morand; Michael P Hier; Manish Khanna; Khalil Sultanem; Alex M Mlynarek
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-09-07

Review 6.  Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.

Authors:  Aaron S Farberg; Alison L Fitzgerald; Sherrif F Ibrahim; Stan N Tolkachjov; Teo Soleymani; Leah M Douglas; Sarah J Kurley; Sarah T Arron
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-07

7.  Extrinsic aging: UV-mediated skin carcinogenesis.

Authors:  Fragkiski Tsatsou; Myrto Trakatelli; Aikaterini Patsatsi; Konstantinos Kalokasidis; Dimitrios Sotiriadis
Journal:  Dermatoendocrinol       Date:  2012-07-01

8.  Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis.

Authors:  Luiza Vasconcelos; Juliana Carneiro Melo; Hélio Amante Miot; Mariângela Esther Alencar Marques; Luciana Patricia Fernandes Abbade
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.